Early Phase 1 Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Part A:
- Adults aged 18 or older (men and women)
- People who have been clinically diagnosed with type 1 diabetes for at least 12 months (no special blood tests are required to confirm the diagnosis — the doctor's judgment is used)
- People who have been using multiple daily insulin injections or an insulin pump for at least 3 months, including those using an automated insulin delivery system
- People whose total daily insulin dose falls between 30 and 100 units per day
- People with enough abdominal (stomach) surface area to wear three study devices at the same time
Part B:
- Adults aged 18 or older (men and women)
- People who have been clinically diagnosed with type 1 diabetes for at least 12 months (no special blood tests are required to confirm the diagnosis — the doctor's judgment is used)
- People who have been using an insulin pump for at least 3 months, including those using an automated insulin delivery system
- People whose total daily insulin dose falls between 30 and 100 units per day
Who may not be able to join:
- People with a serious medical condition that the trial doctor believes would interfere with taking part in or completing the study
- People who are unlikely to follow the study instructions or the team's recommendations
- People who have used any blood sugar-lowering medication other than insulin recently — within the past month for GLP-1 receptor agonists, or within the past week for other types
- Women who are able to become pregnant and are currently pregnant, breastfeeding, or not willing to use effective contraception during the study (a pregnancy test will be done at the first visit)
- People who have had a severe low blood sugar episode within the past month
- People who have had a severe diabetic ketoacidosis episode within the past month
- People with significant kidney, nerve, or eye complications related to diabetes, as judged by the trial doctor
- People who have had a serious heart or blood vessel event — such as a heart attack or heart surgery — within the past 6 months
- People who have been using high doses of steroid medications (above normal body levels) currently or within the past month
- People who have significant areas of hardened or thickened fatty tissue on their abdomen (stomach area) that could affect how devices or insulin work
- People with insufficient abdominal surface area to wear three study devices at the same time (Part A only)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 647 274 4133
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximum post-bolus difference between DPP CGM sensor glucose and YSI plasma glucose; Time to maximum post-bolus difference between DPP CGM sensor glucose and YSI plasma glucose; Time to full recovery of DPP CGM sensor signal following bolus insulin delivery; Percent of DPP CGM sensor values meeting 20/20 agreement criteria vs reference glucose; Percent time in glucose ranges based on Dexcom G7 (Time in Range / Time Below / Time Above); Mean absolute relative difference (MARD) of DPP CGM vs reference glucose; Mean absolute deviation (MAD) of DPP CGM vs reference glucose by basal rate; Bias of D...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.